Company Filing History:
1 out of 2 
1 out of 9 Years Active: 2016-2018
Title: The Innovations of Torben Lebmann
Introduction
Torben Lebmann is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of modified human growth hormone compounds. With a total of two patents to his name, his work has the potential to impact the treatment of various growth disorders.
Latest Patents
Lebmann's latest patents focus on PEGylated recombinant human growth hormone compounds. These compounds are chemically modified human growth hormones (rhGH) that utilize a transient linker comprising polyethylene glycol. The modifications allow for a longer-lasting activity of rhGH compared to unmodified versions. This innovation enables reduced dosing and scheduling opportunities, while also minimizing the risk of lipoatrophy. The patents also include methods for treating and preventing diseases or disorders where growth hormone usage is beneficial.
Career Highlights
Throughout his career, Torben Lebmann has worked with Ascendis Pharma, specifically in their Growth Disorders Division and Endocrinology Division. His experience in these divisions has allowed him to focus on developing innovative solutions for growth-related health issues.
Collaborations
Lebmann has collaborated with notable colleagues such as Harald Rau and Grethe Norskov Rasmussen. Their combined expertise has contributed to the advancements in the field of growth hormone therapies.
Conclusion
Torben Lebmann's work in the field of biotechnology, particularly with PEGylated recombinant human growth hormone compounds, showcases his innovative spirit and dedication to improving health outcomes. His contributions are paving the way for more effective treatments in growth disorders.